The ether endocannabinoid. Noladin ether is the family's third identified member — an unusually stable ether-linked ligand with a pharmacology all its own.
Identified in 2001, noladin ether is arachidonyl alcohol linked to glycerol by an ether bond — a design that resists the esterases that dismantle anandamide and 2-AG. Its endogenous levels and biosynthetic route have proven difficult to confirm, and part of the literature remains cautious about its status as a transmitter — an honest open question in a field that moved fast.
Receptor Actions
CB1 agonism: potent binding, functional effects on synaptic transmission like the family's other ligands.
Weak CB2 activity — a centrally biased profile.
Stability against hydrolysis implies longer signaling windows than its ester cousins.